James Investment Research Inc. Has $2.88 Million Stock Position in McKesson Corporation $MCK

Key Points

• James Investment Research Inc. increased its stake in McKesson by 409.1% in Q4, buying 2,823 shares to hold 3,513 shares valued at $2.88 million, according to its latest 13F filing.
• McKesson beat quarterly estimates with EPS of $9.34 and revenue of $106.16 billion (up 11.4% YoY), and set FY2026 guidance of 38.80–39.20 EPS, near analyst consensus of about 39.02.
• The company has a market cap of $101.45 billion, a P/E of 23.82, pays a quarterly dividend of $0.82 (annualized $3.28, yield ~0.4%), and institutional investors own about 85.07% of the stock while insiders have been net sellers recently.

James Investment Research Inc. increased its stake in shares of McKesson Corporation (NYSE:MCK - Free Report) by 409.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,513 shares of the company's stock after buying an additional 2,823 shares during the period. James Investment Research Inc.'s holdings in McKesson were worth $2,882,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of McKesson by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 12,104,719 shares of the company's stock valued at $9,929,380,000 after purchasing an additional 73,109 shares in the last quarter. State Street Corp boosted its position in McKesson by 0.9% during the third quarter. State Street Corp now owns 5,750,519 shares of the company's stock valued at $4,447,110,000 after acquiring an additional 51,510 shares during the last quarter. Franklin Resources Inc. grew its position in shares of McKesson by 3.5% during the 3rd quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock worth $2,071,428,000 after buying an additional 90,948 shares during the period. Alliancebernstein L.P. grew its stake in shares of McKesson by 5.6% in the 3rd quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock valued at $1,850,001,000 after buying an additional 126,684 shares during the period. Finally, Northern Trust Corp increased its stake in McKesson by 0.4% during the 3rd quarter. Northern Trust Corp now owns 1,532,856 shares of the company's stock valued at $1,184,193,000 after purchasing an additional 6,613 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Price Performance

MCK stock opened at $828.27 on Monday. The company has a market cap of $101.45 billion, a P/E ratio of 23.82, a PEG ratio of 1.19 and a beta of 0.42. The firm has a 50-day moving average of $904.11 and a 200 day moving average of $858.73. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm's revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts expect that McKesson Corporation will post 39.02 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a $0.82 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson's dividend payout ratio is currently 9.43%.

Insider Buying and Selling at McKesson

In related news, Director Maria Martinez sold 349 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director owned 301 shares of the company's stock, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Leann B. Smith sold 190 shares of the company's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 3,592 shares of company stock valued at $3,518,555 over the last 90 days. 0.08% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on MCK. UBS Group cut their price target on shares of McKesson from $1,012.00 to $1,000.00 and set a "buy" rating on the stock in a report on Wednesday, April 22nd. JPMorgan Chase & Co. upped their target price on shares of McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a report on Tuesday, February 10th. Mizuho raised their price target on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a report on Thursday, February 5th. Weiss Ratings downgraded shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. Finally, Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, McKesson presently has a consensus rating of "Moderate Buy" and a consensus price target of $972.27.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.